Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03862937
Other study ID # FUHSPortoAlegre2019
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date March 3, 2019
Est. completion date December 20, 2019

Study information

Verified date July 2020
Source Federal University of Health Science of Porto Alegre
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The increase in life expectancy of the world population is associated with a higher incidence of diseases, leading to functional incapacity and dependence in old age. Aging is usually accompanied by progressive loss of muscle mass, muscular strength and functional capacity, possibly exacerbated by inactivity and low protein and energy consumption of elderly individuals. However, the response to strength training, as well as the daily recommendation of protein and other factors related to sarcopenia in this population seem not to be well understood. Objective: To evaluate the effect of protein intake and resistance training on body composition, muscle strength and functional capacity in the elderly. METHODS: A randomized placebo-controlled clinical trial will be conducted with 38 elderly people, ≥ 60 years old, sedentary, and body mass index between 22 and 30 kg / m2. All those who agree to participate will be randomized into two groups (intervention or placebo) and will undergo an initial assessment consisting of food consumption analysis through the application of the three-day food record, assessment of muscle thickness of the thigh and arm by muscle ultrasonography, evaluation of body composition by dual energy X-ray absorptiometry (DEXA), dynamic maximal strength (1RM) test of knee extension and elbow flexion, peak torque test of knee extension, functional capacity tests and quality of life questionnaire (SF-36). The elderly will participate in resistance training for 12 weeks, two session per week. The intervention group will be supplemented with whey protein isolate (2x / day - 20g for breakfast and 20g for dinner) and the placebo group will receive maltodextrin (2x / day - 20g for breakfast and 20g for dinner). All outcomes will be assessed before and after the 12-week resistance training period.


Recruitment information / eligibility

Status Completed
Enrollment 38
Est. completion date December 20, 2019
Est. primary completion date December 20, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 60 Years to 80 Years
Eligibility Inclusion Criteria:

- Be 60 or older, and in the case of women, they must be postmenopausal (interruption of menstruation for more than one year).

- Have not participated in any systematic exercise program for at least six months prior to the start of this project.

- To have a body mass index (BMI) between 22 and 30 kg / m2.

- Are not cardiopathic, diabetic or have any other metabolic disease.

- Do not present joint problems or any other injury that prevents the proper execution of the exercises of the training routine.

- Non-smoker or have quit smoking for at least five years ago.

- Release of the doctor (medical certificate) to perform the physical exercises.

Exclusion Criteria:

- Do not participate in at least 20 training sessions or miss more than three consecutive training sessions.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Exercise training + whey protein
Whey protein (2x / day - 20g for breakfast and 20g for dinner).
Other:
Exercise training + placebo (maltodextrin)
Maltodextrin (2x / day - 20g for breakfast and 20g for dinner).

Locations

Country Name City State
Brazil Federal University of Health Sciences Porto Alegre Rio Grande Do Sul

Sponsors (1)

Lead Sponsor Collaborator
Federal University of Health Science of Porto Alegre

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Densitometry by dual energy X-ray absorptiometry (DEXA) change from baseline. Measure body composition, such as total fat mass (kg), total fat-free mass (kg), and fat-free mass in the thigh (kg) will be assessed using Dual Energy X-Ray Absorption Densitometry (HXD) (Hologic Discovery W, USA). This measure will be performed before and after the intervention (12 weeks resistance training and supplementation).
Primary Ultrasonography change from baseline. The evaluation of muscle thickness of the quadriceps femoris muscles, as well as the brachial and brachial biceps will be done by means of an image obtained using the Ulio XG ultrasound device (Toshiba, Japan). This measure will be performed before and after the intervention (12 weeks resistance training and supplementation).
Primary Muscular strength (peak of torque) change from baseline. The torque production rate will be calculated from the torque-time curves obtained during a maximal voluntary isometric contraction of knee extension performed on an isokinetic dynamometer (Cybex, Ronkonkoma, USA). This measure will be performed before and after the intervention (12 weeks resistance training and supplementation).
Primary Muscular strength (1-RM) change from baseline. The 1-RM tests (1 maximum repetition test) of knee extension and elbow flexion will be performed in an extensor chair and Scott bench, respectively (Mark Können Gym, China), bilaterally. This measure will be performed before and after the intervention (12 weeks resistance training and supplementation).
Primary Functional capacity (sit and stand up test) change from baseline. The number of sit and stand movements in the chair will be evaluated in 30 seconds. This measure will be performed before and after the intervention (12-week resistance training and supplementation).
Primary Functional capacity (timed up and go test) change from baseline. The task will be to walk a three-meter course, get around a cone, go back and sit in the chair. The result will be expressed in seconds. This measure will be performed before and after the intervention (12-week resistance training and supplementation).
Primary Functional capacity (stair climbing test) change from baseline. Task to climb a flight of stairs at a comfortable speed and without the aid of the handrail and the time will be measured in seconds. This measure will be performed before and after the intervention (12-week resistance training and supplementation).
Secondary Protein intake (dietary record) baseline. To evaluate the food consumption will be used the dietary record of three days.
Secondary Protein intake (24-hour food recall). To verify possible changes in dietary intake over the 12 weeks of intervention, a 24-hour food recall will be applied on the fourth and eighth week and immediately after the last training session.
Secondary Diet Quality Index. To evaluate the quality of the diet will be used the Healthy Eating Index (HEI) that assigns scores to the diet according to the adequacy of the food and nutrients intake, based on the 24 hour reminders previously applied.
Secondary Quality of life (SF-36) change from baseline. This measure will be performed before and after the intervention (12-week resistance training and supplementation). The SF-36 (Medical Outcomes Study 36) questionnaire will be used to evaluate the quality of life of the elderly.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06287502 - Efficacy of Structured Exercise-Nutritional Intervention on Sarcopenia in Patients With Osteoporosis N/A
Recruiting NCT05063279 - RELIEF - Resistance Training for Life N/A
Completed NCT03644030 - Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
Recruiting NCT06143592 - Inspiratory Muscle Training on Balance, Falls and Diaphragm Thickness in the Elderly N/A
Terminated NCT04350762 - Nutritional Supplementation in the Elderly With Weight Loss N/A
Enrolling by invitation NCT05953116 - Managing the Nutritional Needs of Older Filipino With Due Attention to Protein Nutrition and Functional Health Study N/A
Recruiting NCT04028206 - Resistance Exercise or Vibration With HMB for Sarcopenia N/A
Enrolling by invitation NCT03297632 - Improving Muscle Strength, Mass and Physical Function in Older Adults N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A
Completed NCT03234920 - Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation After Liver Transplantation N/A
Recruiting NCT03998202 - Myopenia and Mechanisms of Chemotherapy Toxicity in Older Adults With Colorectal Cancer
Recruiting NCT04717869 - Identifying Modifiable PAtient Centered Therapeutics (IMPACT) Frailty
Completed NCT05497687 - Strength-building Lifestyle-integrated Intervention N/A
Completed NCT03119610 - The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity Phase 1/Phase 2
Recruiting NCT05711095 - The Anabolic Properties of Fortified Plant-based Protein in Older People N/A
Recruiting NCT05008770 - Trial in Elderly With Musculoskeletal Problems Due to Underlying Sarcopenia - Faeces to Unravel Gut and Inflammation Translationally
Not yet recruiting NCT05860556 - Sustainable Eating Pattern to Limit Malnutrition in Older Adults
Recruiting NCT04545268 - Prehabilitation for Cardiac Surgery in Patients With Reduced Exercise Tolerance N/A
Recruiting NCT04522609 - Electrostimulation of Skeletal Muscles in Patients Listed for a Heart Transplant N/A
Recruiting NCT03160326 - The QUALITY Vets Project: Muscle Quality and Kidney Disease